Rapid Micro Biosystems, Inc. (RPID)
Largest Insider Buys in Sector
RPID Stock Price History Chart
RPID Stock Performance
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Insider Activity of Rapid Micro Biosystems, Inc.
Over the last 12 months, insiders at Rapid Micro Biosystems, Inc. have bought $162,662 and sold $0 worth of Rapid Micro Biosystems, Inc. stock.
On average, over the past 5 years, insiders at Rapid Micro Biosystems, Inc. have bought $1.41M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kollender Richard S (director) — $50,128. Malloy Kirk (director) — $45,335. Spignesi Robert G. Jr. (PRESIDENT AND CEO) — $38,400.
The last purchase of 19,892 shares for transaction amount of $20,887 was made by PEI MELINDA LITHERLAND (director) on 2024‑11‑27.
List of Insider Buy and Sell Transactions, Rapid Micro Biosystems, Inc.
| 2024-11-27 | director | 19,892 0.0481% | $1.05 | $20,887 | +6.05% | |||
| 2024-11-26 | director | 108 0.0002% | $1.04 | $112 | -2.85% | |||
| 2024-08-08 | director | 50,000 0.123% | $0.91 | $45,335 | +3.44% | |||
| 2024-08-07 | CHIEF FINANCIAL OFFICER | 10,000 0.0243% | $0.78 | $7,800 | +17.20% | |||
| 2024-08-06 | PRESIDENT AND CEO | 50,000 0.1147% | $0.77 | $38,400 | +12.55% | |||
| 2024-08-06 | director | 65,000 0.1497% | $0.77 | $50,128 | +12.55% | |||
| 2023-09-06 | CHIEF FINANCIAL OFFICER | 10,000 0.024% | $0.99 | $9,894 | -1.44% | |||
| 2023-08-15 | PRESIDENT AND CEO | 20,000 0.046% | $0.97 | $19,488 | -3.50% | |||
| 2023-08-08 | PRESIDENT AND CEO | 34,000 0.0817% | $0.92 | $31,447 | +5.98% | |||
| 2023-05-17 | PRESIDENT AND CEO | 20,000 0.0462% | $0.91 | $18,204 | +6.63% | |||
| 2022-06-02 | 20,602 0.0446% | $4.66 | $96,100 | -62.92% | ||||
| 2022-05-27 | 19,414 0.0406% | $4.76 | $92,407 | -58.50% | ||||
| 2022-05-25 | 12,396 0.0323% | $4.90 | $60,774 | -49.44% | ||||
| 2022-05-17 | 11,125 0.0243% | $3.94 | $43,861 | -43.29% | ||||
| 2022-05-16 | President and CEO | 10,000 0.0234% | $3.79 | $37,950 | -35.86% | |||
| 2022-03-10 | 10,000 0.0262% | $6.95 | $69,500 | -46.34% | ||||
| 2021-07-19 | 10 percent owner | 100,000 0.2804% | $20.00 | $2M | -59.26% | |||
| 2021-07-19 | 10 percent owner | 150,000 0.4205% | $20.00 | $3M | -59.26% |
Insider Historical Profitability
| Spignesi Robert G. Jr. | PRESIDENT AND CEO | 540012 1.2548% | $1.05 | 5 | 0 | <0.0001% |
| WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | 348157 0.809% | $1.05 | 2 | 0 | |
| Kollender Richard S | director | 96718 0.2247% | $1.05 | 1 | 0 | |
| Malloy Kirk | director | 64300 0.1494% | $1.05 | 1 | 0 | |
| PEI MELINDA LITHERLAND | director | 34300 0.0797% | $1.05 | 2 | 0 | |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | 8434560 19.5997% | $1.05 | 1 | 0 | <0.0001% |
| CHENE DAVID | 2035441 4.7298% | $1.05 | 4 | 0 | <0.0001% | |
| Longitude Capital Partners II, LLC | 10 percent owner | 150000 0.3486% | $1.05 | 1 | 0 | <0.0001% |
| LOWENSTEIN INESE | 10000 0.0232% | $1.05 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Bain Capital Life Sciences Investors Llc | $8.18M | 19.68 | 8.43M | 0% | +$0 | 0.66 | |
| Kennedy Lewis Management Lp | $4.79M | 11.53 | 4.94M | 0% | +$0 | 13.34 | |
| Glenview Capital Management | $1.28M | 3.08 | 1.32M | 0% | +$0 | 0.03 | |
| Abg Wtt Global Life Science Capital Partners Gp Ltd | $768,339.00 | 2.42 | 1.04M | 0% | +$0 | 1.85 | |
| BlackRock | $989,136.00 | 2.38 | 1.02M | -0.17% | -$1,677.13 | <0.0001 | |
| The Vanguard Group | $706,629.00 | 1.7 | 728,484 | +0.01% | +$106.70 | <0.0001 | |
| JPMorgan Chase | $604,146.00 | 1.45 | 622,831 | -17.1% | -$124,626.55 | <0.0001 | |
| International Corp/ma Advent | $560,444.00 | 1.35 | 577,777 | 0% | +$0 | 0.01 | |
| Geode Capital Management | $156,372.00 | 0.38 | 161,153 | +3.79% | +$5,714.29 | <0.0001 | |
| Millennium Management LLC | $64,201.00 | 0.15 | 66,187 | +285.37% | +$47,541.35 | <0.0001 | |
| Renaissance Technologies | $56,000.00 | 0.13 | 57,387 | -26.32% | -$20,004.53 | <0.0001 | |
| State Street | $25,292.00 | 0.06 | 26,074 | 0% | +$0 | <0.0001 | |
| Goldman Sachs | $18,080.00 | 0.04 | 18,639 | -91.46% | -$193,660.38 | <0.0001 | |
| Northern Trust | $15,181.00 | 0.04 | 15,650 | 0% | +$0 | <0.0001 | |
| Virtu Financial Llc | $11,000.00 | 0.03 | 10,880 | -32.27% | -$5,241.18 | <0.01 | |
| Morgan Stanley | $9,805.00 | 0.02 | 10,108 | -5.04% | -$519.93 | <0.0001 | |
| Tower Research Capital | $5,381.00 | 0.01 | 5,547 | -43.44% | -$4,132.52 | <0.0001 | |
| UBS | $239.00 | <0.01 | 246 | New | +$239.00 | <0.0001 | |
| Resources Management Corp Ct Adv | $0 | <0.01 | 500 | 0% | +$0 | <0.0001 | |
| Bank of America | $81.00 | <0.01 | 83 | +492.86% | +$67.34 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 60 | -76% | -$0 | <0.0001 | |
| Qube Research & Technologies | $4.00 | <0.01 | 4 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $152.00 | <0.01 | 157 | +1.95% | +$2.90 | <0.0001 |